Summary
CVS Health Corporation (CVS) filed an 8-K on October 20, 2008, to report significant progress in its acquisition of Longs Drug Stores Corporation. The filing details the results of the initial tender offer period, which saw a substantial majority of Longs' outstanding shares tendered and accepted for purchase. This successful tender offer paves the way for the planned merger to be completed, making Longs an indirect wholly owned subsidiary of CVS. Investors should note that CVS has commenced a subsequent offering period to acquire any remaining shares not tendered initially, at the same offer price. The merger is expected to finalize by the end of October 2008. This acquisition represents a major strategic move for CVS, likely aimed at expanding its retail pharmacy footprint and potentially integrating Longs' operations into its broader healthcare services model.
Key Highlights
- 1CVS Caremark Corporation successfully completed the initial tender offer period for Longs Drug Stores Corporation shares.
- 2Approximately 76.51% of Longs' outstanding shares were tendered and accepted for purchase at $71.50 per share.
- 3A subsequent offering period has commenced, allowing remaining shareholders to tender their shares at the same price until October 28, 2008.
- 4All untendered shares will be acquired for cash at the offer price upon the completion of the merger.
- 5The merger is expected to be completed by the end of October 2008, making Longs an indirect wholly owned subsidiary of CVS.
- 6This filing confirms the significant progress and near-completion of the Longs Drug Stores acquisition by CVS.